Andere Kunden interessierten sich auch für
![Neurodegenerative Disorders: Loss of Function Through Gain of Function]( "Neurodegenerative Disorders: Loss of Function Through Gain of Function")
Neurodegenerative Disorders: Loss of Function Through Gain of Function125,99 €![Intracellular Traffic and Neurodegenerative Disorders]( "Intracellular Traffic and Neurodegenerative Disorders")
Intracellular Traffic and Neurodegenerative Disorders147,99 €![Intracellular Traffic and Neurodegenerative Disorders]( "Intracellular Traffic and Neurodegenerative Disorders")
Intracellular Traffic and Neurodegenerative Disorders147,99 €![Genotype - Proteotype - Phenotype Relationships in Neurodegenerative Diseases]( "Genotype - Proteotype - Phenotype Relationships in Neurodegenerative Diseases")
Genotype - Proteotype - Phenotype Relationships in Neurodegenerative Diseases110,99 €![Genotype - Proteotype - Phenotype Relationships in Neurodegenerative Diseases]( "Genotype - Proteotype - Phenotype Relationships in Neurodegenerative Diseases")
Genotype - Proteotype - Phenotype Relationships in Neurodegenerative Diseases125,99 €![Notch from Neurodevelopment to Neurodegeneration: Keeping the Fate]( "Notch from Neurodevelopment to Neurodegeneration: Keeping the Fate")
Notch from Neurodevelopment to Neurodegeneration: Keeping the Fate125,99 €![Fatal Attractions: Protein Aggregates in Neurodegenerative Disorders]( "Fatal Attractions: Protein Aggregates in Neurodegenerative Disorders")
Fatal Attractions: Protein Aggregates in Neurodegenerative Disorders166,99 €
The main message from this book is that the different protein aggregation processes may all be amenable to a small number of intervention steps based on a common theme of the modulation of production, turnover and deposition of the corresponding disease gene products. The next few years will prove critical in evaluation the possibilities of rational therapeutic strategies towards regaining the loss of function through the amelioration of the abnormal gain of function.
Fondation Ipsen sponsored a meeting in Paris in February 2000 on the emerging paradigm-shift in our understanding of the major degenerative diseases which affect the aging human brain. This book sumarizes our deliberations on some of these major neurodegenerative diseases that are characterized by protein depos its, and that are due to the pathogenic gain of function of an otherwise normal neuronal protein. For each of the major human neurodegenerative diseases covered in this book -the most prominent being Alzheimer's disease -experimental models are described, including cell culture systems and animal models which range from the round worm, Caenorhabditis elegans, the fruitfly, Drosophila melanogaster, to rodents. Remarkably, in the sporadic forms of these human diseases, only a minor change in the level of production or turn-over of the relevant proteins is sufficient to cause disease in late adult-hood. Neurodegeneration in Alzheimer's disease, for example, usually results insymptoms and signs in the seventh to eighth decades. In contrast, the development of protein deposits in transgenic mice over-expressing the corresponding disease gene parallels the genetic forms of the human diseases in regard to its manifestation occuring half-way through its normal life-span, i. e. about 50 years in humans (the so-called "presenium") and 9 to 12 months in the mouse. Nevertheless, these models have served to elu cidate many of the pathways underlying the human disease processes, for instance clarifying the neuronal origin of parenchymal and perivascular amyloid in Alzheimer's disease and Creutzfeldt-Jakob disease.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Fondation Ipsen sponsored a meeting in Paris in February 2000 on the emerging paradigm-shift in our understanding of the major degenerative diseases which affect the aging human brain. This book sumarizes our deliberations on some of these major neurodegenerative diseases that are characterized by protein depos its, and that are due to the pathogenic gain of function of an otherwise normal neuronal protein. For each of the major human neurodegenerative diseases covered in this book -the most prominent being Alzheimer's disease -experimental models are described, including cell culture systems and animal models which range from the round worm, Caenorhabditis elegans, the fruitfly, Drosophila melanogaster, to rodents. Remarkably, in the sporadic forms of these human diseases, only a minor change in the level of production or turn-over of the relevant proteins is sufficient to cause disease in late adult-hood. Neurodegeneration in Alzheimer's disease, for example, usually results insymptoms and signs in the seventh to eighth decades. In contrast, the development of protein deposits in transgenic mice over-expressing the corresponding disease gene parallels the genetic forms of the human diseases in regard to its manifestation occuring half-way through its normal life-span, i. e. about 50 years in humans (the so-called "presenium") and 9 to 12 months in the mouse. Nevertheless, these models have served to elu cidate many of the pathways underlying the human disease processes, for instance clarifying the neuronal origin of parenchymal and perivascular amyloid in Alzheimer's disease and Creutzfeldt-Jakob disease.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.